메뉴 건너뛰기




Volumn 5, Issue 2, 2011, Pages 81-85

Law-medicine interfacing: Patenting of human genes and mutations

Author keywords

BRCA1 BRCA2 genes; Breast cancer; Drug efficacy; Gene patents; Genetic predisposition; Genetic testing; Human genome; Patent validity; Pharmacogenetics; Protein drugs

Indexed keywords

ACYLTRANSFERASE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIMALARIAL AGENT; ANTINEOPLASTIC AGENT; AZURIN; BRCA1 PROTEIN; BRCA2 PROTEIN; CLOPIDOGREL; CODEINE; CYTOCHROME P450 1A1; CYTOCHROME P450 2D6; FLUOXETINE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE M3; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; LAZ; TRASTUZUMAB; UNCLASSIFIED DRUG; WARFARIN;

EID: 79959971559     PISSN: 18722156     EISSN: None     Source Type: Journal    
DOI: 10.2174/187221511796392015     Document Type: Article
Times cited : (2)

References (31)
  • 1
    • 0036594079 scopus 로고    scopus 로고
    • How can you patent genes?
    • Eisenberg RS. How can you patent genes? Am J Bioeth 2002; 2: 3-11.
    • (2002) Am J Bioeth , vol.2 , pp. 3-11
    • Eisenberg, R.S.1
  • 2
    • 33748516792 scopus 로고    scopus 로고
    • Evidence and anecdotes: An analysis of human gene patenting controversies
    • Caulfield T, Cook-Deegan RM, Kieff FS, Walsh JP. Evidence and anecdotes: an analysis of human gene patenting controversies. Nat Biotechnol 2006; 24: 1091-4.
    • (2006) Nat Biotechnol , vol.24 , pp. 1091-1094
    • Caulfield, T.1    Cook-Deegan, R.M.2    Kieff, F.S.3    Walsh, J.P.4
  • 4
    • 0032076895 scopus 로고    scopus 로고
    • The patenting of DNA
    • Doll JJ. The patenting of DNA. Science 1998; 280: 689-90.
    • (1998) Science , vol.280 , pp. 689-690
    • Doll, J.J.1
  • 5
    • 79959945938 scopus 로고    scopus 로고
    • United States Patent and Trademark Office 1337 CNOG 859, December 30, 2008
    • CREATE Act Examination Guidelines, United States Patent and Trademark Office 1337 CNOG 859, December 30, 2008.
    • CREATE Act Examination Guidelines
  • 14
    • 77951150520 scopus 로고    scopus 로고
    • Chasing a disease to the vanishing point
    • Couzin-Frankel J. Chasing a disease to the vanishing point. Science 2010; 328: 298-300.
    • (2010) Science , vol.328 , pp. 298-300
    • Couzin-Frankel, J.1
  • 15
    • 77950250064 scopus 로고    scopus 로고
    • Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5
    • Vijay-Kumar M, Aitken JD, Carvalho FA, et al. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 2010; 328: 228-31.
    • (2010) Science , vol.328 , pp. 228-231
    • Vijay-Kumar, M.1    Aitken, J.D.2    Carvalho, F.A.3
  • 17
    • 0242492893 scopus 로고    scopus 로고
    • Environmental biotechnology in the postgenomics era
    • Chakrabarty AM. Environmental biotechnology in the postgenomics era. Biotech Adv 2003; 22: 3-8.
    • (2003) Biotech Adv , vol.22 , pp. 3-8
    • Chakrabarty, A.M.1
  • 18
    • 77954496054 scopus 로고    scopus 로고
    • Pharmacogenetics raises new legal questions
    • Hutson S. Pharmacogenetics raises new legal questions. Nat Med 2010; 16: 729.
    • (2010) Nat Med , vol.16 , pp. 729
    • Hutson, S.1
  • 19
    • 77957550798 scopus 로고    scopus 로고
    • Bioengineered bugs, drugs and contentious issues in patenting
    • Chakrabarty AM. Bioengineered bugs, drugs and contentious issues in patenting. Bioeng Bugs 2010; 1: 2-8.
    • (2010) Bioeng Bugs , vol.1 , pp. 2-8
    • Chakrabarty, A.M.1
  • 31
    • 76149134398 scopus 로고    scopus 로고
    • IPSCs: One cell to rule them all?
    • Eisenstein M. IPSCs: one cell to rule them all? Nat Methods 2010; 7: 81-4.
    • (2010) Nat Methods , vol.7 , pp. 81-84
    • Eisenstein, M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.